GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $226,000 | +9.2% | 5,191 | +9.4% | 0.01% | +27.3% |
| Q1 2022 | $207,000 | +27.0% | 4,743 | +28.7% | 0.01% | +37.5% |
| Q4 2021 | $163,000 | +19.0% | 3,685 | +2.8% | 0.01% | +14.3% |
| Q3 2021 | $137,000 | -42.9% | 3,585 | -40.4% | 0.01% | -46.2% |
| Q2 2021 | $240,000 | -7.3% | 6,014 | -17.2% | 0.01% | -13.3% |
| Q1 2021 | $259,000 | -4.4% | 7,264 | -1.4% | 0.02% | -6.2% |
| Q4 2020 | $271,000 | -2.5% | 7,367 | 0.0% | 0.02% | -15.8% |
| Q3 2020 | $278,000 | -7.3% | 7,367 | 0.0% | 0.02% | -13.6% |
| Q2 2020 | $300,000 | +7.5% | 7,367 | 0.0% | 0.02% | -12.0% |
| Q1 2020 | $279,000 | -20.7% | 7,367 | -1.8% | 0.02% | -3.8% |
| Q4 2019 | $352,000 | +5.7% | 7,503 | -4.0% | 0.03% | 0.0% |
| Q3 2019 | $333,000 | +3.1% | 7,818 | -3.1% | 0.03% | 0.0% |
| Q2 2019 | $323,000 | -14.3% | 8,065 | -10.5% | 0.03% | -18.8% |
| Q1 2019 | $377,000 | -3.1% | 9,015 | -11.5% | 0.03% | -13.5% |
| Q4 2018 | $389,000 | -18.1% | 10,185 | -13.8% | 0.04% | -5.1% |
| Q3 2018 | $475,000 | -39.4% | 11,821 | -39.2% | 0.04% | -42.6% |
| Q2 2018 | $784,000 | +3.2% | 19,447 | 0.0% | 0.07% | +1.5% |
| Q1 2018 | $760,000 | +83.1% | 19,447 | +66.5% | 0.07% | +76.3% |
| Q4 2017 | $415,000 | -23.1% | 11,680 | -12.3% | 0.04% | -26.9% |
| Q3 2017 | $540,000 | -3.1% | 13,311 | +3.1% | 0.05% | -5.5% |
| Q2 2017 | $557,000 | +3.3% | 12,915 | +1.2% | 0.06% | +1.9% |
| Q1 2017 | $539,000 | +7.4% | 12,765 | -2.1% | 0.05% | +3.8% |
| Q4 2016 | $502,000 | -8.7% | 13,042 | +2.2% | 0.05% | -11.9% |
| Q3 2016 | $550,000 | +1.5% | 12,765 | +2.2% | 0.06% | -4.8% |
| Q2 2016 | $542,000 | +3.8% | 12,485 | -3.0% | 0.06% | +3.3% |
| Q1 2016 | $522,000 | +0.8% | 12,876 | +0.3% | 0.06% | -1.6% |
| Q4 2015 | $518,000 | +1.8% | 12,835 | -3.1% | 0.06% | -1.6% |
| Q3 2015 | $509,000 | +1.8% | 13,239 | +10.3% | 0.06% | +8.8% |
| Q2 2015 | $500,000 | -4.4% | 12,004 | +5.8% | 0.06% | -6.6% |
| Q1 2015 | $523,000 | +237.4% | 11,344 | +212.6% | 0.06% | +221.1% |
| Q4 2014 | $155,000 | -11.9% | 3,629 | -5.2% | 0.02% | -13.6% |
| Q3 2014 | $176,000 | +29.4% | 3,829 | +51.0% | 0.02% | +29.4% |
| Q2 2014 | $136,000 | +0.7% | 2,536 | 0.0% | 0.02% | -19.0% |
| Q1 2014 | $135,000 | +11.6% | 2,536 | +11.6% | 0.02% | +23.5% |
| Q4 2013 | $121,000 | +6.1% | 2,272 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $114,000 | 0.0% | 2,272 | 0.0% | 0.02% | -5.6% |
| Q2 2013 | $114,000 | – | 2,272 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |